Delivery Order HHSN271201700005I-75N95020F00002
Award Date 9/21/20
Potential Completion Date 3/31/26
Potential Value $1.8M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albany, NY 12212, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for "CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL" and was issued to Curia Global Inc., doing business as Amri. The contract, valued at $907,791.77, is a delivery order under the "CRO Support for NCATS Drug Substance Development and Manufacture" indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The National Center for Advancing Translational...
- This federal contract award to Curia Global Inc., doing business as Amri, is for the production of non-GMP (non-Good Manufacturing Practice) batches of the drug substances paynantheine, speciogynine, and speciociliatine salts. The contract, valued at $1,259,570.66, was awarded under the National Institute on Drug Abuse's (NIDA) indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle for Contract Research Organization (CRO) Support for NCATS Drug Substance Development and Manufacture....
- This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $2,873,042.91 contract is for the Medicinal Chemistry Support Program for Therapeutic Development, under which Curia will provide a range of chemistry, manufacturing, and controls development...
- This is a delivery order awarded to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The $662,706.10 cost-plus-fixed-fee contract is to provide chemistry and absorption/distribution/metabolism/excretion (ADMET) services in support of the Medicinal Chemistry Support Program (MCSP) and other NIH initiatives related to neurology, infectious diseases, and...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Curia Global Inc. (doing business as Amri), a for-profit organization and manufacturer of goods. The award, valued at $610,340.86, is a delivery order under the Nonclinical Services for Development of Interventional Agents indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract directs Curia to prepare 400 grams of non-GMP (good manufacturing practice)...
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $3,173,498.83 cost-plus-fixed-fee Delivery Order contract to Curia Global Inc., doing business as Amri, for Exploratory Chemistry services under the Medicinal Chemistry Support Program for Therapeutic Development. The contract has a completion date of February 1, 2026 and does not have a small business set-aside designation. Curia, a global contract...
- This federal contract task order was awarded by the U.S. Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The $1,376,049.53 cost-plus-fixed-fee task order, awarded on August 15, 2018, supports the Medicinal Chemistry Support Program for Therapeutic Development, providing chemistry, manufacturing, and controls...
- This federal contract award is for the manufacture of 5.5-kg of cGMP mitragynine, a drug substance, by Curia Global Inc. (doing business as Amri). The award, with a ceiling value of $3,370,313.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the Department of Health and Human Services. This is a delivery order under the CRO Support for NCATS Drug Substance Development and Manufacture indefinite-delivery/indefinite-quantity (IDIQ)...
- This is a federal contract award to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The contract, valued at $3,360,769.23, is for the Medicinal Chemistry Support Program for Therapeutic Development (MCSP-EC), which involves exploratory chemistry services. The contract has a completion date of November 13, 2025 and was awarded on May 6, 2022. Curia Global is a...
- This federal contract award to Curia Global Inc., doing business as AMRI, is for chemistry and manufacturing services related to the chemical synthesis and process optimization of the compound STF-1759. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract has a ceiling value of $411,404.73 and a period of performance through September 30, 2021. It is a cost-plus-fixed-fee...